The role of cytokines and hot flashes in perimenopausal depression

Annals of General Psychiatry

Volumn 11, Issue , 2012, Pages

  Karaoulanis, Sokratis E ^a   Daponte, Alexandros ^a   Rizouli, Katerina A ^a   Rizoulis, Andreas A ^b   Lialios, Georgios A ^a   Theodoridou, Catherine T ^a   Christakopoulos, Christos ^c   Angelopoulos, Nikiforos V ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b Psychiatric Hospital of Attiki   (Greece)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Antidepressants; Cytokines; Depression; Hot flashes; Interleukin 10 (IL 10); Interleukin 6 (IL 6); Perimenopause; Tumor necrosis factor (TNF )

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; SEROTONIN UPTAKE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLIMACTERIUM; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HOT FLUSH; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE RATING SCALE; PERIMENOPAUSAL DEPRESSION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RATING SCALE;

EID: 84859483371     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-11-9     Document Type: Article

References (39)

1. Bromberger JT, Matthews KA, Schott LL, Brockwell S, Avis NE, Kravitz HM, Everson-Rose SA, Gold EB, Sowers M, Randolph JF. Depressive symptoms during the menopausal transition: The Study of Women's Health Across the Nation (SWAN). J Affect Disord 2007, 103:267-272. 10.1016/j.jad.2007.01.034, 2048765, 17331589.
2. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Arch Gen Psychiatry 2006, 63:385-390. 10.1001/archpsyc.63.4.385, 16585467.
3. Rasgon N, Shelton S, Halbreich U. Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr 2005, 10:471-478.
4. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009, 34:4-20. 2612083, 19125209.
5. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741. 10.1016/j.biopsych.2008.11.029, 2680424, 19150053.
6. Muller N, Schwartz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007, 12:988-1000. 10.1038/sj.mp.4002006, 17457312.
7. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31. 10.1016/j.it.2005.11.006, 16316783.
8. Schiepers OJG, Wichers MC, Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-217. 10.1016/j.pnpbp.2004.11.003, 15694227.
9. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL. A meta-analysis of cytokines in major depression. Biol Psychiatry 2009, 67:446-457.
10. Maes M, Smith R, Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995, 20:111-116. 10.1016/0306-4530(94)00066-J, 7899532.
11. Hepgul N, Mondelli V, Pariante CM. Psychological and biological mechanisms of cytokine induced depression. Epidemiol Psichiatr Soc 2010, 19:98-102.
12. Cioffi M, Esposito K, Vietri MT, Gazzerro P, D'Auria A, Ardovino I, Puca GA, Molinari AM. Cytokine pattern in postmenopause. Maturitas 2002, 41:187-192. 10.1016/S0378-5122(01)00286-9, 11886764.
13. Ushiroyama T, Ikeda A, Ueki M. Elevated plasma interleukin 6 (IL-6) and soluble IL-6 receptor concentrations in menopausal women with and without depression. Int J Gynecol Obstet 2002, 79:51-52.
14. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Tsuchiya N, Yuzurihara M, Takeda S, Irahara M. Association of interleukin-8 with hot flashes in premenopausal, perimenopausal and postmenopausal women and bilateral oophorectomized women. J Clin Endocrinol Metab 2006, 91:4805-4808. 10.1210/jc.2006-1100, 17018658.
15. Gyllstrom EM, Schreiner PJ, Harlow BL. Perimenopause and depression: strength of association, causal mechanisms and treatment recommendations. Best Pract Res Clin Obstet Gynecol 2007, 21:275-292.
16. Parry BL. Perimenopausal depression. Am J Psychiatry 2008, 165:23-27.
17. Hauser GA, Huber IC, Keller PJ, Lauritzen C, Schneider HPG. Evaluation der klinischen Beschwerden (Menopause Rating Scale). Zentralbl Gynakol 1994, 116:16-23.
18. Schneider HPG, Heinemann LAJ, Rosemeier HP, Potthoff P, Behre HM. The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric 2000, 3:59-64. 10.3109/13697130009167600, 11910611.
19. Blom EH, Lekander M, Ingvar M, Asberg M, Mobarrez F, Serlachius E. Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord 2012, 136:716-723. 10.1016/j.jad.2011.10.002, 22056230.
20. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E Ranjan R, Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995, 34:301-309. 10.1016/0165-0327(95)00028-L, 8550956.
21. Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, Kubera M, Bob P, Lerer B, Maj M. The inflammatory & neurodegenerative (I & ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24:27-53. 10.1007/s11011-008-9118-1, 19085093.
22. O'Brien SM, Scott LV, Dinan TG. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol 2004, 19:397-403. 10.1002/hup.609, 15303243.
23. Alexander JL, Dennerstein L, Woods NF, McEwen BS, Halbreich U, Kotz K, Richardson G. Role of stressful life events and menopausal stage in wellbeing and health. Exp Rev Neurother 2007, 7:s93-S113.
24. Hayley S. Toward an anti-inflammatoty strategy for depression. Front Behav Neurosci 2011, 5:1-7. 3024828, 21267359.
25. Pfeilschifter J, Koditz R, Pfohl M, Schatz. Changes in proinflammatory cytokine activity after menopause. Endocrine Rev 2002, 23:90-119.
26. Arnason PGW, Reder AT. Cell-mediated immunity and neurologic disease. Diseases of the Nervous System 1991, Philadelphia, PA: WB Saunders, Mackhann GM, McDonald WI.
27. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol 1999, 6:89. 95666, 9874670.
28. Bromberger JT, Kravitz HM, Matthews K, Youk A, Brown C, Feng W. Predictors of first lifetime episodes of major depression in midlife women. Psychol Med 2009, 39:55-64. 10.1017/S0033291708003218, 2905863, 18377672.
29. Freeman EW. Associations of depression with the transition to menopause. Menopause 2010, 17:823-827. 10.1097/gme.0b013e3181db9f8b, 20531231.
30. Freeman EW, Sammel MD, Lin H. Temporal associations of hot flashes and depression in the transition to menopause. Menopause 2009, 16:728-734. 10.1097/gme.0b013e3181967e16, 2860597, 19188849.
31. Joffe HJ, Hall JE, Soares CN, Hennen J, Reilly CJ, Carlson K, Cohen LS. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002, 9:392-398. 10.1097/00042192-200211000-00003, 12439097.
32. Juang K-D, Wang S-J, Lu S-R, Lee S-J, Fuh J-L. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women. Maturitas 2005, 52:119-126. 10.1016/j.maturitas.2005.01.005, 16186074.
33. Seritan AL, Iosif AM, Park JH, Deatheragehand D, Sweet RL, Gold EB. Self reported anxiety, depressive and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center. Menopause 2010, 17:410-415. 10.1097/gme.0b013e3181bf5a62, 20216277.
34. Ozturk O, Eraslan D, Mete HE, Ozsener S. The risk factors and symptomatology of perimenopausal depression. Maturitas 2006, 55:180-186. 10.1016/j.maturitas.2006.02.001, 16581210.
35. Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, Goka E. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol Clin Exp 2005, 20:473-476.
36. Yasui T, Yamada M, Uemura H, Ueno S, Numata S, Ohmori T, Tsuchiya N, Noguchi M, Yuzurihara M, Kase Y, Irahara M. Changes in circulating cytokine levels in midlife women with psychological symptoms with selective serotonin reuptake inhibitors and Japanese traditional medicine. Maturitas 2009, 62:146-152. 10.1016/j.maturitas.2008.12.007, 19179025.
37. O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatric Res 2007, 41:326-331.
38. Minghini A, Britt LD, Hill MA. Interleukin-1 and interleukin-6 mediated skeletal muscle arteriolar vasodilation: in vitro versus in vivo studies. Shock 1998, 9:210-215. 10.1097/00024382-199803000-00009, 9525329.
39. Patel JN, Jager A, Schalkwijk C, Corder R, Douthwaite JA, Yudkin JS, Coppack SW, Stehouwer CD. Effects of tumour necrosis factor-α in the human forearm: blood flow and endothelin-1 release. Clin Sci 2002, 103:409-415.